Literature DB >> 23238981

Fulminant course of osteonecrosis of the jaw in a rheumatoid arthritis patient following oral bisphosphonate intake and biologic therapy.

Tobias Ebker, Juergen Rech, Cornelius von Wilmowsky, Friedrich Wilhelm Neukam, Philipp Stockmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23238981     DOI： 10.1093/rheumatology/kes351

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  6 in total

1.  Osteonecrosis of the jaw in a Crohn's disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report.

Authors:  Raimund H M Preidl; Tobias Ebker; Martin Raithel; Falk Wehrhan; Friedrich W Neukam; Philipp Stockmann
Journal:  BMC Gastroenterol       Date:  2014-01-08       Impact factor: 3.067

2.  A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab.

Authors:  Gianfranco Favia; Angela Tempesta; Luisa Limongelli; Vito Crincoli; Florenzo Iannone; Giovanni Lapadula; Eugenio Maiorano
Journal:  Am J Case Rep       Date:  2017-12-19

3.  Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition.

Authors:  Mario Migliario; Giovanni Mergoni; Paolo Vescovi; Iolanda De Martino; Manuela Alessio; Luca Benzi; Filippo Renò; Vittorio Fusco
Journal:  Dent J (Basel)       Date:  2017-03-16

Review 4.  Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies.

Authors:  Raed AlRowis; Abdulmalik Aldawood; Mohammed AlOtaibi; Essam Alnasser; Ibrahim AlSaif; Abdullah Aljaber; Zuhair Natto
Journal:  Saudi Dent J       Date:  2022-01-19

Review 5.  The role of antiresorptive drugs and medication-related osteonecrosis of the jaw in nononcologic immunosuppressed patients: A systematic review.

Authors:  Roberto Sacco; Julian Woolley; Julian Yates; Monica Diuana Calasans-Maia; Oladapo Akintola; Vinod Patel
Journal:  J Res Med Sci       Date:  2021-03-31       Impact factor: 1.852

6.  New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws.

Authors:  Francesco Bennardo; Caterina Buffone; Amerigo Giudice
Journal:  Oral Oncol       Date:  2020-03-21       Impact factor: 5.337
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.